M&A Deal Summary

Topotarget A/S Acquires Valerio Therapeutics

On April 16, 2014, Topotarget A/S acquired life science company Valerio Therapeutics from Idinvest Partners for 230M USD

Acquisition Highlights
  • This is Topotarget A/S’s 1st transaction in the Life Science sector.
  • This is Topotarget A/S’s largest (disclosed) transaction.
  • This is Topotarget A/S’s 1st transaction in France.

M&A Deal Summary
Date 2014-04-16
Target Valerio Therapeutics
Sector Life Science
Buyer(s) Topotarget A/S
Sellers(s) Idinvest Partners
Deal Type Merger
Deal Value 230M USD
Advisor(s) Centerview Partners
Nordea Markets
Grant Thornton Transaction Services (Financial)
Bech-Bruun (Legal)

Target

Valerio Therapeutics

Paris, France
Valerio Therapeutics is a clinical-stage biotechnology company developing innovative oncology drugs targeting tumor DNA-binding functions through unique mechanisms of action in the sought-after field of DNA Damage Response (DDR). The Company is focused on bringing early-stage first-in-class or disruptive compounds from translational research to clinical proof-of-concept, a value-creating inflection point appealing to potential partners. Valerio Therapeutics was founded in 1997 and is based in Paris, France.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Topotarget A/S

Copenhagen, Denmark
Category Company
Founded 2000
Sector Life Science
DESCRIPTION

Topotarget is a provider of clinical development and registration of oncology products. In collaboration with Spectrum Pharmaceuticals, Inc., Topotarget focuses on the development of its lead drug candidate, belinostat, which has shown positive results in the treatment of hematological malignancies and solid tumors, obtained by both mono- and combination therapy.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Merger) 1 of 1
Country (France) 1 of 1
Year (2014) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-29 Topotarget USA

Rockaway, New Jersey, United States

Topotarget USA, Inc. is a biotechnology company.

Sell -

Seller(S) 1

SELLER

Idinvest Partners

Paris, France
Category Private Equity Firm
Founded 1997
PE ASSETS 7.6B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Idinvest Partners is a European investment firm focused on investing in small to mid-sized companies at various stages of development. Idinvest segments its investment activity into three groups. These include venture and growth capital, private debt, and dedicated portfolios/funds. Idinvest's venture and growth capital group looks to invest directly in early stage companies with high growth potential. Idinvest's private debt group seeks to provide senior or subordinated debt to small and mid-sized companies pursuing growth objectives. Idinvest's dedicated portfolio/funds group looks to invest in private equity funds, acquire secondary fund positions, and directly co-invest alongside other private equity firms in established companies. Idinvest Partners was formed in 1997 and is based in Paris.

DEAL STATS #
Overall 21 of 38
Sector (Life Science) 4 of 5
Type (Merger) 1 of 1
Country (France) 15 of 24
Year (2014) 3 of 4
Size (of disclosed) 5 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-04-04 Genticel S.A.

Labège-Innopole, France

Genticel S.A. is a biotechnology company specialized in the development of a vaccine against infection responsible for uterin cancers. Genticel was formed in 2001 and is based in Labège-Innopole, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-04-29 Leosphere

Orsay, France

Leosphere is a high-tech company located in Paris Region with a focus on atmospheric LIDAR sensing. Leosphere was founded in 2004 and is based in Orsay, France.

Buy -
Mergr

Product

Company

Legal